Coming soon: Female Viagra
April 14th, 2010 - 12:11 pm ICT by ANIWashington, Apr 14 (ANI): A female equivalent of Viagra could soon be available to help women achieve the Big O, claim scientists.
A team working for Pfizer, the pharmaceutical firm behind Viagra, in Sandwich, Kent, has uncovered a substance that boosts female sexual arousal, increasing her chance of orgasm.
The findings could pave the way for a drug similar in effect to Viagra, which has helped countless men.
In the study, using a novel prototype drug, researchers discovered more about the mechanisms underlying female sexual arousal.
The finding is published in the British Journal of Pharmacology.
The boffins found that electrically stimulating the pelvic nerve increases blood flow to the genitalia, and that this effect was enhanced if they also gave a prototype drug (UK-414,495).
They believe that the drug acts by blocking the breakdown of an internal chemical messenger that plays a key role in increasing blood flow during sexual arousal.
When women become aroused, blood flow increases to the vagina, labia and clitoris. This causes the organs to swell, and the vagina to relax, as well as increasing vaginal lubrication and the sensitivity of the genitalia.
Female sexual arousal disorder (FSAD) affects up to 40percent of women irrespective of age. These women find that their genital organs do not respond to sexual stimulation, they find arousal difficult and this causes them to become distressed.
“Before this work, we knew surprisingly little about the processes that control all of these changes,” says the lead researcher in the project Chris Wayman. “Now we are beginning to establish the pathways involved in sexual arousal scientists may be able to find ways of helping women who would like to overcome FSAD.”
In the study, researchers stimulated the pelvic nerve and measured changes in genital organs. They believed the genital arousal occurred because stimulation of the nerve triggered the release of vasoactive intestinal peptide (VIP), a well-known neurotransmitter. VIP has only a short-lived effect, because it is soon broken down by an enzyme called Neutral Endopeptidase (NEP). The researchers believe that their prototype drug increased the arousal because it blocked NEP’s ability to break down VIP, therefore letting the VIP have a more powerful and prolonged effect increasing arousal. (ANI)
- Drug prototype shows promise of female arousal - Apr 14, 2010
- Booze puts Brits in the mood for sex: Study - Feb 24, 2011
- Statins may help treat 'female sexual dysfunction' - Sep 09, 2009
- Viagra can help in foetal development in humans - Feb 04, 2010
- Women in red a real turn off for men - Apr 17, 2012
- Two-third of women face sexual problems and orgasm is biggest of them all - Jul 28, 2010
- Resistant gonorrhoea strain may threaten global health - Jul 11, 2011
- Just four out of ten patients know they have genital herpes - Apr 12, 2011
- Women need to chat to pep up libido - Sep 19, 2010
- Men can do well with ginseng, saffron - Mar 28, 2011
- Pharma companies 'medicalising' low-libido to boost sales of female 'Viagra' - Oct 01, 2010
- List of A-Z love bites! - Feb 09, 2010
- Claims of sexual dysfunction in females overrated, says new book - Sep 28, 2010
- Wanna 'spice' up your sex life? Add these natural enhancers in diet - Mar 28, 2011
- A good chat 'may be enough to improve women's sex lives' - Sep 17, 2010
Tags: boffins, british journal of pharmacology, chemical messenger, claim scientists, countless men, drug researchers, female equivalent, female sexual arousal disorder, flow increases, fsad, genital organs, genitalia, intestinal peptide, pelvic nerve, pharmaceutical firm, sandwich kent, sexual arousal disorder, sexual stimulation, study researchers, vaginal lubrication